| 19.5 |
58.5 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 15.8 |
47.5 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 12.2 |
48.9 |
GO:0003330 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 12.1 |
48.3 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 12.1 |
48.3 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 12.0 |
47.8 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 11.1 |
66.5 |
GO:1902847 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 10.5 |
42.1 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 10.5 |
41.8 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) |
| 10.3 |
31.0 |
GO:1990168 |
protein K33-linked deubiquitination(GO:1990168) |
| 10.3 |
144.6 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 9.8 |
29.3 |
GO:2000296 |
negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 9.5 |
9.5 |
GO:1901655 |
cellular response to ketone(GO:1901655) |
| 9.4 |
18.8 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 9.2 |
45.9 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 9.1 |
27.2 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 9.0 |
27.1 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 8.9 |
35.7 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 8.7 |
43.3 |
GO:0048807 |
female genitalia morphogenesis(GO:0048807) |
| 8.4 |
33.4 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 8.3 |
8.3 |
GO:0043650 |
glutamate biosynthetic process(GO:0006537) dicarboxylic acid biosynthetic process(GO:0043650) |
| 8.2 |
16.4 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 7.8 |
15.7 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 7.8 |
23.4 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 7.8 |
7.8 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 7.7 |
15.5 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 7.5 |
29.9 |
GO:0006208 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 7.4 |
36.9 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 7.3 |
36.4 |
GO:0072313 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 7.2 |
21.6 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 7.0 |
20.9 |
GO:0048691 |
modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 6.9 |
34.4 |
GO:0034442 |
regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
| 6.8 |
27.2 |
GO:1902612 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 6.7 |
67.4 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 6.7 |
20.2 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 6.5 |
6.5 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
| 6.3 |
31.7 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 6.3 |
18.9 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 6.0 |
23.8 |
GO:0035054 |
embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 5.7 |
17.2 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 5.7 |
28.6 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 5.7 |
17.1 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 5.7 |
17.1 |
GO:0021718 |
superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 5.7 |
28.3 |
GO:0044856 |
plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 5.6 |
22.4 |
GO:0071231 |
cellular response to folic acid(GO:0071231) |
| 5.6 |
16.7 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 5.6 |
27.8 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 5.4 |
16.2 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 5.3 |
26.7 |
GO:0030070 |
insulin processing(GO:0030070) |
| 5.3 |
5.3 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 5.3 |
10.6 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 5.3 |
68.5 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 5.2 |
15.7 |
GO:0033861 |
negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 5.2 |
15.5 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 5.1 |
5.1 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 5.1 |
15.4 |
GO:0035603 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 5.0 |
15.1 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 5.0 |
5.0 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 4.9 |
14.8 |
GO:1990764 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 4.9 |
24.5 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 4.9 |
9.8 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 4.9 |
19.5 |
GO:0061364 |
apoptotic process involved in luteolysis(GO:0061364) |
| 4.8 |
9.7 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 4.8 |
19.2 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 4.8 |
14.3 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 4.7 |
18.8 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 4.7 |
14.1 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 4.7 |
23.3 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 4.6 |
18.5 |
GO:0072376 |
protein activation cascade(GO:0072376) |
| 4.6 |
23.1 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 4.6 |
13.7 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 4.5 |
22.7 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 4.5 |
58.7 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 4.5 |
17.9 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 4.5 |
13.4 |
GO:0033212 |
iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 4.5 |
13.4 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 4.5 |
13.4 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 4.5 |
13.4 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 4.4 |
26.5 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 4.4 |
22.0 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 4.4 |
17.6 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 4.4 |
4.4 |
GO:0060734 |
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 4.3 |
17.1 |
GO:0042361 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 4.3 |
12.8 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 4.3 |
34.1 |
GO:0015705 |
iodide transport(GO:0015705) |
| 4.2 |
12.7 |
GO:1904204 |
regulation of skeletal muscle hypertrophy(GO:1904204) |
| 4.2 |
16.9 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 4.2 |
96.1 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 4.2 |
33.3 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 4.2 |
4.2 |
GO:0006145 |
purine nucleobase catabolic process(GO:0006145) |
| 4.1 |
49.8 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 4.1 |
49.5 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 4.1 |
16.2 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 4.0 |
24.2 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 4.0 |
12.0 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 4.0 |
4.0 |
GO:2000302 |
positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 4.0 |
32.0 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 4.0 |
12.0 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 4.0 |
23.8 |
GO:2000322 |
regulation of glucocorticoid receptor signaling pathway(GO:2000322) negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 3.9 |
15.7 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 3.9 |
3.9 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 3.9 |
27.3 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 3.9 |
11.7 |
GO:0032887 |
regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 3.9 |
11.6 |
GO:0015888 |
thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 3.8 |
42.1 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 3.8 |
19.1 |
GO:0051946 |
regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 3.8 |
3.8 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 3.8 |
30.5 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 3.8 |
15.2 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 3.8 |
11.3 |
GO:1905154 |
negative regulation of membrane invagination(GO:1905154) |
| 3.8 |
11.3 |
GO:0038188 |
cholecystokinin signaling pathway(GO:0038188) |
| 3.7 |
14.8 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 3.7 |
11.0 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 3.7 |
40.5 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 3.7 |
14.6 |
GO:0042335 |
cuticle development(GO:0042335) |
| 3.6 |
10.9 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 3.6 |
10.9 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 3.6 |
3.6 |
GO:0032344 |
regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
| 3.6 |
10.8 |
GO:1904640 |
response to methionine(GO:1904640) |
| 3.6 |
10.7 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 3.5 |
10.6 |
GO:0035915 |
pore formation in membrane of other organism(GO:0035915) |
| 3.5 |
63.6 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 3.5 |
7.1 |
GO:0001501 |
skeletal system development(GO:0001501) |
| 3.5 |
3.5 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 3.5 |
13.9 |
GO:0097113 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 3.5 |
20.8 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 3.5 |
10.4 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 3.4 |
3.4 |
GO:2000584 |
regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 3.4 |
6.9 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 3.4 |
3.4 |
GO:0003285 |
septum secundum development(GO:0003285) |
| 3.4 |
3.4 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 3.4 |
10.1 |
GO:2001303 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 3.4 |
10.1 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 3.3 |
13.4 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 3.3 |
13.3 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 3.3 |
32.9 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 3.3 |
22.9 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 3.3 |
13.1 |
GO:0021633 |
optic nerve structural organization(GO:0021633) |
| 3.3 |
9.8 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 3.2 |
22.7 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 3.2 |
9.7 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 3.2 |
9.7 |
GO:0051037 |
histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 3.2 |
25.7 |
GO:0006531 |
aspartate metabolic process(GO:0006531) |
| 3.2 |
12.8 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 3.2 |
9.5 |
GO:0002125 |
maternal aggressive behavior(GO:0002125) |
| 3.2 |
18.9 |
GO:0010873 |
positive regulation of cholesterol esterification(GO:0010873) |
| 3.1 |
9.4 |
GO:0019470 |
4-hydroxyproline catabolic process(GO:0019470) |
| 3.1 |
3.1 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 3.1 |
3.1 |
GO:0099545 |
trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
| 3.1 |
6.2 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 3.1 |
18.7 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 3.1 |
37.3 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 3.1 |
9.3 |
GO:0048241 |
epinephrine transport(GO:0048241) |
| 3.1 |
27.7 |
GO:0036017 |
response to erythropoietin(GO:0036017) |
| 3.1 |
21.5 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 3.1 |
3.1 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 3.1 |
6.1 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 3.1 |
6.1 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 3.0 |
18.1 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 3.0 |
6.0 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 3.0 |
24.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 3.0 |
3.0 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) |
| 3.0 |
17.8 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 3.0 |
3.0 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 3.0 |
8.9 |
GO:0030311 |
poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 2.9 |
38.1 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 2.9 |
2.9 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 2.9 |
14.6 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 2.9 |
8.7 |
GO:0044278 |
cell wall disruption in other organism(GO:0044278) |
| 2.9 |
8.7 |
GO:1902722 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) positive regulation of prolactin secretion(GO:1902722) |
| 2.9 |
2.9 |
GO:0046487 |
glyoxylate metabolic process(GO:0046487) |
| 2.9 |
11.5 |
GO:0044334 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 2.9 |
11.5 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 2.8 |
2.8 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 2.8 |
2.8 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 2.8 |
8.5 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 2.8 |
8.5 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 2.8 |
19.7 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 2.8 |
14.0 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 2.8 |
27.9 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 2.8 |
30.6 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 2.8 |
44.5 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 2.8 |
38.8 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 2.8 |
22.1 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
| 2.8 |
8.3 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 2.7 |
8.2 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 2.7 |
8.2 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 2.7 |
32.6 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 2.7 |
8.1 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 2.7 |
13.5 |
GO:1902731 |
negative regulation of chondrocyte proliferation(GO:1902731) |
| 2.7 |
24.0 |
GO:0051552 |
flavone metabolic process(GO:0051552) |
| 2.7 |
8.0 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 2.7 |
10.6 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) |
| 2.6 |
10.6 |
GO:0032972 |
regulation of muscle filament sliding speed(GO:0032972) |
| 2.6 |
7.9 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 2.6 |
2.6 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 2.6 |
7.9 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 2.6 |
7.9 |
GO:1901624 |
negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 2.6 |
10.5 |
GO:0016098 |
monoterpenoid metabolic process(GO:0016098) |
| 2.6 |
10.5 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 2.6 |
10.5 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 2.6 |
7.9 |
GO:1902081 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 2.6 |
23.5 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 2.6 |
10.5 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 2.6 |
7.8 |
GO:0061055 |
myotome development(GO:0061055) |
| 2.6 |
38.8 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 2.6 |
46.4 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 2.6 |
7.7 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 2.6 |
5.1 |
GO:0051659 |
maintenance of mitochondrion location(GO:0051659) |
| 2.6 |
2.6 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 2.6 |
18.0 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 2.6 |
10.2 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 2.6 |
2.6 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 2.5 |
5.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 2.5 |
7.6 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 2.5 |
2.5 |
GO:0042761 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation(GO:0030497) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) very long-chain fatty acid biosynthetic process(GO:0042761) |
| 2.5 |
10.1 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 2.5 |
15.1 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 2.5 |
30.2 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 2.5 |
10.0 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 2.5 |
14.9 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 2.5 |
49.1 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 2.4 |
2.4 |
GO:0014734 |
skeletal muscle hypertrophy(GO:0014734) |
| 2.4 |
12.2 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 2.4 |
19.5 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 2.4 |
4.8 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 2.4 |
7.2 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 2.4 |
38.5 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 2.4 |
7.1 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 2.4 |
7.1 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 2.4 |
16.5 |
GO:0019720 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 2.3 |
14.1 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 2.3 |
7.0 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 2.3 |
6.9 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 2.3 |
11.6 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 2.3 |
9.2 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 2.3 |
9.2 |
GO:0001519 |
peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 2.3 |
13.8 |
GO:0052565 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 2.3 |
4.6 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 2.3 |
11.4 |
GO:0010665 |
regulation of cardiac muscle cell apoptotic process(GO:0010665) |
| 2.2 |
2.2 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 2.2 |
51.4 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 2.2 |
4.4 |
GO:0070781 |
response to biotin(GO:0070781) |
| 2.2 |
4.4 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 2.2 |
17.7 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 2.2 |
24.1 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 2.2 |
26.2 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 2.2 |
4.4 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 2.2 |
43.3 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 2.2 |
6.5 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 2.2 |
19.4 |
GO:0051410 |
detoxification of nitrogen compound(GO:0051410) |
| 2.2 |
6.5 |
GO:1905146 |
lysosomal protein catabolic process(GO:1905146) |
| 2.1 |
27.8 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 2.1 |
8.6 |
GO:0038170 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 2.1 |
61.9 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 2.1 |
4.3 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 2.1 |
4.2 |
GO:0060605 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 2.1 |
8.5 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 2.1 |
4.2 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 2.1 |
6.3 |
GO:0090210 |
regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 2.1 |
2.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 2.1 |
8.4 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) |
| 2.1 |
6.3 |
GO:0061536 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 2.1 |
20.8 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 2.1 |
2.1 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 2.1 |
18.5 |
GO:0007507 |
heart development(GO:0007507) |
| 2.1 |
6.2 |
GO:0061534 |
gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 2.1 |
2.1 |
GO:0070370 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 2.0 |
8.2 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 2.0 |
8.2 |
GO:0015872 |
dopamine transport(GO:0015872) |
| 2.0 |
24.5 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 2.0 |
12.2 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 2.0 |
4.1 |
GO:1901877 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 2.0 |
34.6 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 2.0 |
2.0 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 2.0 |
54.7 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 2.0 |
6.1 |
GO:1904823 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 2.0 |
6.1 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 2.0 |
6.0 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 2.0 |
10.1 |
GO:0036102 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 2.0 |
4.0 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 2.0 |
6.0 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 2.0 |
8.0 |
GO:2000170 |
negative regulation of gap junction assembly(GO:1903597) positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 2.0 |
13.9 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 2.0 |
2.0 |
GO:0015840 |
urea transport(GO:0015840) |
| 2.0 |
7.9 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 2.0 |
3.9 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 2.0 |
3.9 |
GO:0001806 |
type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
| 2.0 |
5.9 |
GO:0043606 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 2.0 |
9.8 |
GO:1904139 |
positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 2.0 |
7.8 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 2.0 |
3.9 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 1.9 |
5.8 |
GO:0019605 |
benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 1.9 |
3.9 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 1.9 |
3.9 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 1.9 |
5.8 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 1.9 |
19.3 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 1.9 |
23.1 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 1.9 |
3.8 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 1.9 |
3.8 |
GO:0060681 |
branch elongation involved in ureteric bud branching(GO:0060681) |
| 1.9 |
11.4 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 1.9 |
5.7 |
GO:0045906 |
negative regulation of vasoconstriction(GO:0045906) |
| 1.9 |
1.9 |
GO:2000389 |
regulation of neutrophil extravasation(GO:2000389) |
| 1.9 |
9.5 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 1.9 |
1.9 |
GO:0019442 |
tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 1.9 |
13.2 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 1.9 |
41.5 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 1.9 |
9.4 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 1.9 |
7.5 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 1.9 |
5.6 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 1.9 |
48.8 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 1.9 |
31.9 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 1.9 |
11.2 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 1.9 |
11.2 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 1.9 |
7.5 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 1.9 |
7.5 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.9 |
11.2 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 1.9 |
11.2 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 1.9 |
1.9 |
GO:0009804 |
coumarin metabolic process(GO:0009804) |
| 1.9 |
18.6 |
GO:0014848 |
urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 1.9 |
7.4 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 1.8 |
9.2 |
GO:0019464 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.8 |
38.6 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 1.8 |
1.8 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 1.8 |
33.0 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 1.8 |
5.5 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 1.8 |
12.7 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) |
| 1.8 |
23.5 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 1.8 |
7.2 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 1.8 |
7.2 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 1.8 |
5.4 |
GO:1902308 |
regulation of peptidyl-serine dephosphorylation(GO:1902308) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 1.8 |
12.5 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.8 |
8.8 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 1.8 |
10.6 |
GO:0036166 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 1.8 |
15.8 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 1.8 |
7.0 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 1.7 |
5.2 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 1.7 |
5.2 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 1.7 |
3.5 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) |
| 1.7 |
5.2 |
GO:0046104 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 1.7 |
45.0 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 1.7 |
1.7 |
GO:2000317 |
negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 1.7 |
12.0 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 1.7 |
39.5 |
GO:0006577 |
amino-acid betaine metabolic process(GO:0006577) |
| 1.7 |
6.9 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 1.7 |
6.8 |
GO:2000343 |
positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 1.7 |
3.4 |
GO:0060285 |
cilium-dependent cell motility(GO:0060285) |
| 1.7 |
10.1 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 1.7 |
16.8 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 1.7 |
21.8 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 1.7 |
1.7 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 1.7 |
5.0 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.7 |
6.7 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 1.7 |
5.0 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 1.7 |
10.0 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 1.6 |
6.6 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 1.6 |
6.5 |
GO:1903935 |
response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 1.6 |
3.3 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 1.6 |
6.5 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 1.6 |
6.5 |
GO:1990418 |
response to insulin-like growth factor stimulus(GO:1990418) |
| 1.6 |
6.5 |
GO:2000722 |
regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) |
| 1.6 |
4.9 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 1.6 |
6.5 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 1.6 |
8.1 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 1.6 |
3.2 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 1.6 |
6.4 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 1.6 |
4.8 |
GO:0003257 |
positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 1.6 |
6.4 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.6 |
1.6 |
GO:0051253 |
negative regulation of RNA metabolic process(GO:0051253) |
| 1.6 |
12.8 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 1.6 |
8.0 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 1.6 |
4.8 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 1.6 |
4.8 |
GO:1903350 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 1.6 |
3.2 |
GO:1903978 |
regulation of microglial cell activation(GO:1903978) |
| 1.6 |
6.3 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 1.6 |
3.2 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 1.6 |
3.1 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 1.6 |
3.1 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 1.6 |
3.1 |
GO:0006335 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 1.6 |
12.5 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 1.6 |
3.1 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 1.6 |
12.5 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 1.6 |
4.7 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 1.6 |
12.5 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 1.6 |
7.8 |
GO:0014827 |
intestine smooth muscle contraction(GO:0014827) |
| 1.6 |
3.1 |
GO:0005985 |
sucrose metabolic process(GO:0005985) |
| 1.5 |
3.1 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of phospholipase A2 activity(GO:0032431) |
| 1.5 |
13.9 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 1.5 |
24.7 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 1.5 |
6.2 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 1.5 |
7.7 |
GO:0060137 |
maternal process involved in parturition(GO:0060137) |
| 1.5 |
6.1 |
GO:1903564 |
regulation of protein localization to cilium(GO:1903564) |
| 1.5 |
9.1 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 1.5 |
4.5 |
GO:0007497 |
posterior midgut development(GO:0007497) positive regulation of penile erection(GO:0060406) endothelin receptor signaling pathway(GO:0086100) |
| 1.5 |
12.1 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 1.5 |
4.5 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
| 1.5 |
3.0 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 1.5 |
7.5 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 1.5 |
4.5 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 1.5 |
6.0 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 1.5 |
10.5 |
GO:0015886 |
heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
| 1.5 |
1.5 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 1.5 |
7.4 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 1.5 |
11.8 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 1.5 |
23.7 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 1.5 |
10.3 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 1.5 |
4.4 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 1.5 |
5.8 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 1.5 |
4.4 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 1.5 |
16.0 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 1.5 |
17.5 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 1.5 |
2.9 |
GO:0051189 |
molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 1.5 |
18.9 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 1.5 |
4.4 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 1.4 |
10.1 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 1.4 |
14.4 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 1.4 |
2.9 |
GO:0072329 |
monocarboxylic acid catabolic process(GO:0072329) |
| 1.4 |
33.0 |
GO:0045821 |
positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 1.4 |
51.6 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 1.4 |
2.9 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 1.4 |
5.7 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 1.4 |
7.1 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 1.4 |
17.1 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 1.4 |
10.0 |
GO:0034115 |
negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 1.4 |
5.7 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) |
| 1.4 |
18.3 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 1.4 |
2.8 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 1.4 |
7.0 |
GO:0072023 |
thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 1.4 |
4.2 |
GO:0061370 |
testosterone biosynthetic process(GO:0061370) |
| 1.4 |
7.0 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 1.4 |
2.8 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 1.4 |
5.6 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 1.4 |
23.6 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 1.4 |
2.8 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 1.4 |
2.8 |
GO:0032900 |
negative regulation of neurotrophin production(GO:0032900) |
| 1.4 |
2.8 |
GO:1902617 |
response to fluoride(GO:1902617) |
| 1.4 |
8.3 |
GO:0002760 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.4 |
2.8 |
GO:1903521 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.4 |
6.9 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 1.4 |
16.5 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 1.4 |
5.5 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 1.4 |
10.9 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 1.4 |
1.4 |
GO:0036378 |
calcitriol biosynthetic process from calciol(GO:0036378) |
| 1.4 |
1.4 |
GO:0051549 |
regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
| 1.4 |
4.1 |
GO:1901993 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 1.4 |
6.8 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 1.4 |
8.1 |
GO:0030917 |
midbrain-hindbrain boundary development(GO:0030917) |
| 1.4 |
4.1 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 1.4 |
2.7 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 1.3 |
14.8 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 1.3 |
25.5 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 1.3 |
10.7 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 1.3 |
8.0 |
GO:0098722 |
asymmetric neuroblast division(GO:0055059) asymmetric stem cell division(GO:0098722) |
| 1.3 |
16.1 |
GO:0051852 |
disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 1.3 |
4.0 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 1.3 |
5.3 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 1.3 |
5.3 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 1.3 |
1.3 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
| 1.3 |
1.3 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 1.3 |
10.5 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 1.3 |
6.6 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.3 |
3.9 |
GO:2001054 |
negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 1.3 |
6.5 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 1.3 |
2.6 |
GO:0042160 |
lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 1.3 |
9.1 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 1.3 |
2.6 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 1.3 |
19.4 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 1.3 |
7.8 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 1.3 |
2.6 |
GO:0060023 |
soft palate development(GO:0060023) |
| 1.3 |
21.9 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 1.3 |
3.9 |
GO:0007418 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 1.3 |
5.1 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 1.3 |
7.7 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 1.3 |
2.6 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 1.3 |
14.0 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 1.3 |
12.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 1.3 |
3.8 |
GO:0038123 |
toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 1.3 |
1.3 |
GO:1900168 |
glial cell-derived neurotrophic factor secretion(GO:0044467) metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 1.3 |
2.5 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 1.3 |
1.3 |
GO:0001554 |
luteolysis(GO:0001554) |
| 1.3 |
2.5 |
GO:0044782 |
cilium organization(GO:0044782) |
| 1.3 |
5.0 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 1.3 |
2.5 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 1.3 |
32.6 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 1.2 |
10.0 |
GO:0097107 |
postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 1.2 |
8.7 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 1.2 |
9.9 |
GO:0000101 |
sulfur amino acid transport(GO:0000101) |
| 1.2 |
7.5 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 1.2 |
1.2 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 1.2 |
19.8 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 1.2 |
3.7 |
GO:0061081 |
positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 1.2 |
6.2 |
GO:1901910 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 1.2 |
2.5 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 1.2 |
4.9 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 1.2 |
8.6 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 1.2 |
2.5 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) |
| 1.2 |
2.4 |
GO:0007520 |
syncytium formation(GO:0006949) myoblast fusion(GO:0007520) |
| 1.2 |
4.9 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 1.2 |
9.8 |
GO:0060746 |
maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 1.2 |
7.3 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 1.2 |
3.6 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 1.2 |
73.7 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 1.2 |
27.8 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.2 |
3.6 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.2 |
9.6 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.2 |
3.6 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 1.2 |
7.2 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 1.2 |
8.4 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 1.2 |
7.2 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 1.2 |
17.9 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 1.2 |
11.9 |
GO:0014894 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 1.2 |
14.2 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 1.2 |
4.7 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 1.2 |
9.4 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 1.2 |
3.5 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 1.2 |
4.6 |
GO:0071503 |
response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 1.2 |
5.8 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 1.1 |
17.2 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 1.1 |
6.9 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.1 |
12.6 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 1.1 |
2.3 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 1.1 |
3.4 |
GO:0098935 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 1.1 |
9.1 |
GO:0071830 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 1.1 |
2.3 |
GO:1902108 |
regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 1.1 |
3.4 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 1.1 |
6.7 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 1.1 |
9.0 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 1.1 |
4.5 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 1.1 |
3.3 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 1.1 |
3.3 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 1.1 |
3.3 |
GO:0070213 |
negative regulation of sister chromatid cohesion(GO:0045875) protein auto-ADP-ribosylation(GO:0070213) |
| 1.1 |
11.0 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 1.1 |
11.0 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 1.1 |
5.5 |
GO:1901731 |
positive regulation of platelet aggregation(GO:1901731) |
| 1.1 |
4.4 |
GO:0021936 |
regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 1.1 |
5.5 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 1.1 |
7.6 |
GO:0001889 |
liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
| 1.1 |
3.2 |
GO:0034372 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
| 1.1 |
5.4 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 1.1 |
7.5 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.1 |
2.2 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 1.1 |
3.2 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 1.1 |
5.4 |
GO:0039663 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 1.1 |
5.4 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 1.1 |
1.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 1.1 |
5.3 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 1.1 |
30.8 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 1.1 |
25.4 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 1.1 |
7.4 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 1.1 |
1.1 |
GO:1900114 |
positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 1.0 |
15.7 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 1.0 |
1.0 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 1.0 |
31.4 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 1.0 |
6.2 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 1.0 |
4.2 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 1.0 |
3.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 1.0 |
9.3 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 1.0 |
4.1 |
GO:0006565 |
L-serine catabolic process(GO:0006565) |
| 1.0 |
51.6 |
GO:0050911 |
detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 1.0 |
5.1 |
GO:0042461 |
photoreceptor cell development(GO:0042461) |
| 1.0 |
1.0 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 1.0 |
1.0 |
GO:0045986 |
negative regulation of smooth muscle contraction(GO:0045986) |
| 1.0 |
3.1 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 1.0 |
4.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 1.0 |
6.1 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 1.0 |
3.0 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 1.0 |
7.1 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 1.0 |
2.0 |
GO:0010966 |
regulation of phosphate transport(GO:0010966) |
| 1.0 |
4.0 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 1.0 |
3.0 |
GO:0006116 |
fructose catabolic process(GO:0006001) NADH oxidation(GO:0006116) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 1.0 |
2.0 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 1.0 |
12.0 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 1.0 |
9.0 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 1.0 |
1.0 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 1.0 |
3.0 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 1.0 |
5.0 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 1.0 |
3.0 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 1.0 |
11.8 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 1.0 |
3.0 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 1.0 |
14.7 |
GO:0099536 |
synaptic signaling(GO:0099536) |
| 1.0 |
14.7 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 1.0 |
2.9 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 1.0 |
9.8 |
GO:0098719 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 1.0 |
8.8 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 1.0 |
1.9 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 1.0 |
3.9 |
GO:0007260 |
tyrosine phosphorylation of STAT protein(GO:0007260) regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
| 1.0 |
15.5 |
GO:0043562 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 1.0 |
4.8 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 1.0 |
6.8 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 1.0 |
7.7 |
GO:0008286 |
insulin receptor signaling pathway(GO:0008286) |
| 1.0 |
2.9 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 1.0 |
15.4 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 1.0 |
6.7 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 1.0 |
9.6 |
GO:0010990 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 1.0 |
17.2 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.9 |
12.3 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.9 |
2.8 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.9 |
2.8 |
GO:0002522 |
leukocyte migration involved in immune response(GO:0002522) |
| 0.9 |
6.6 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.9 |
5.7 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.9 |
6.6 |
GO:0090306 |
spindle assembly involved in meiosis(GO:0090306) |
| 0.9 |
3.8 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.9 |
16.9 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.9 |
18.7 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.9 |
0.9 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.9 |
8.4 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.9 |
1.9 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.9 |
1.9 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.9 |
2.8 |
GO:1903795 |
regulation of anion channel activity(GO:0010359) positive regulation of anion channel activity(GO:1901529) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) positive regulation of anion transmembrane transport(GO:1903961) |
| 0.9 |
10.1 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.9 |
2.8 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.9 |
6.4 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.9 |
16.5 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.9 |
20.1 |
GO:1901687 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.9 |
2.7 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.9 |
1.8 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.9 |
3.6 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.9 |
3.6 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.9 |
0.9 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.9 |
3.6 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.9 |
6.3 |
GO:0006935 |
chemotaxis(GO:0006935) taxis(GO:0042330) |
| 0.9 |
2.7 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.9 |
13.4 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.9 |
8.8 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.9 |
3.5 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.9 |
7.0 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.9 |
7.0 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.9 |
10.4 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.9 |
6.1 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.9 |
16.5 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.9 |
7.8 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.9 |
2.6 |
GO:0003229 |
ventricular cardiac muscle tissue development(GO:0003229) |
| 0.9 |
3.5 |
GO:0097210 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.9 |
5.2 |
GO:0097491 |
sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
| 0.9 |
2.6 |
GO:0097359 |
UDP-glucosylation(GO:0097359) |
| 0.9 |
5.2 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.9 |
1.7 |
GO:0042476 |
odontogenesis(GO:0042476) |
| 0.9 |
6.0 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.9 |
2.6 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.9 |
8.5 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.8 |
3.4 |
GO:1902307 |
positive regulation of sodium ion transmembrane transport(GO:1902307) positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.8 |
11.0 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.8 |
1.7 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.8 |
7.6 |
GO:0050942 |
regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.8 |
13.5 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.8 |
1.7 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.8 |
2.5 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.8 |
14.2 |
GO:0060850 |
regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.8 |
5.8 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.8 |
2.5 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.8 |
2.5 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.8 |
3.3 |
GO:0034959 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.8 |
2.5 |
GO:0099531 |
neurotransmitter secretion(GO:0007269) presynaptic process involved in chemical synaptic transmission(GO:0099531) signal release from synapse(GO:0099643) |
| 0.8 |
2.5 |
GO:0051715 |
cytolysis in other organism(GO:0051715) |
| 0.8 |
2.5 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) |
| 0.8 |
4.1 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.8 |
2.4 |
GO:0044254 |
angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.8 |
4.9 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.8 |
8.1 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.8 |
3.2 |
GO:0007270 |
neuron-neuron synaptic transmission(GO:0007270) |
| 0.8 |
8.9 |
GO:0010663 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.8 |
4.8 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.8 |
5.6 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.8 |
6.4 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.8 |
3.9 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.8 |
0.8 |
GO:0006349 |
regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.8 |
3.1 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.8 |
5.5 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.8 |
6.3 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.8 |
1.5 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.8 |
3.8 |
GO:0097398 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.8 |
1.5 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.8 |
32.9 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.8 |
9.9 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.8 |
2.3 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 0.8 |
9.9 |
GO:0006833 |
water transport(GO:0006833) |
| 0.8 |
4.6 |
GO:0014010 |
Schwann cell proliferation(GO:0014010) |
| 0.8 |
6.8 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.8 |
1.5 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.8 |
4.5 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.8 |
4.5 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.8 |
5.3 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.8 |
1.5 |
GO:1902548 |
negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.7 |
2.2 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.7 |
0.7 |
GO:0050905 |
neuromuscular process(GO:0050905) |
| 0.7 |
9.6 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.7 |
4.4 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.7 |
4.4 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.7 |
3.7 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.7 |
4.4 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.7 |
16.9 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.7 |
2.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.7 |
1.5 |
GO:0097466 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) response to glycoprotein(GO:1904587) |
| 0.7 |
27.7 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.7 |
2.9 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.7 |
2.9 |
GO:0038194 |
thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.7 |
2.9 |
GO:0072402 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.7 |
2.2 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.7 |
7.2 |
GO:0032720 |
negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
| 0.7 |
3.6 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.7 |
4.3 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.7 |
0.7 |
GO:0051940 |
regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 0.7 |
7.8 |
GO:0017156 |
calcium ion regulated exocytosis(GO:0017156) |
| 0.7 |
2.8 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.7 |
4.2 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.7 |
2.1 |
GO:0030187 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.7 |
2.1 |
GO:0050428 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.7 |
5.6 |
GO:0021895 |
cerebral cortex neuron differentiation(GO:0021895) |
| 0.7 |
0.7 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.7 |
9.8 |
GO:0046320 |
regulation of fatty acid oxidation(GO:0046320) |
| 0.7 |
1.4 |
GO:0072007 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) |
| 0.7 |
0.7 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.7 |
9.0 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.7 |
3.5 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.7 |
4.8 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.7 |
2.1 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.7 |
9.0 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.7 |
1.4 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.7 |
3.4 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.7 |
7.5 |
GO:0001759 |
organ induction(GO:0001759) |
| 0.7 |
98.7 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.7 |
6.1 |
GO:0036124 |
histone H3-K9 trimethylation(GO:0036124) |
| 0.7 |
2.7 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.7 |
1.3 |
GO:0033129 |
positive regulation of histone phosphorylation(GO:0033129) |
| 0.7 |
10.1 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) bile acid metabolic process(GO:0008206) |
| 0.7 |
2.0 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.7 |
0.7 |
GO:0030104 |
water homeostasis(GO:0030104) |
| 0.7 |
2.0 |
GO:1905097 |
regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
| 0.7 |
2.7 |
GO:0070572 |
positive regulation of neuron projection regeneration(GO:0070572) |
| 0.7 |
3.3 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.7 |
7.3 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.7 |
1.3 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.7 |
0.7 |
GO:0060298 |
positive regulation of sarcomere organization(GO:0060298) |
| 0.7 |
13.1 |
GO:0008038 |
neuron recognition(GO:0008038) |
| 0.7 |
2.6 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.7 |
2.0 |
GO:0002027 |
regulation of heart rate(GO:0002027) |
| 0.6 |
3.9 |
GO:0070875 |
positive regulation of glycogen metabolic process(GO:0070875) |
| 0.6 |
24.0 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.6 |
10.4 |
GO:0060512 |
prostate gland morphogenesis(GO:0060512) |
| 0.6 |
2.6 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.6 |
1.3 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.6 |
13.5 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.6 |
3.9 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.6 |
1.3 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.6 |
1.3 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.6 |
6.4 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.6 |
1.9 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.6 |
0.6 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) regulation of melanosome organization(GO:1903056) |
| 0.6 |
17.0 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.6 |
3.8 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.6 |
0.6 |
GO:0032754 |
positive regulation of interleukin-5 production(GO:0032754) |
| 0.6 |
8.1 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.6 |
0.6 |
GO:0014074 |
response to purine-containing compound(GO:0014074) |
| 0.6 |
1.2 |
GO:0046885 |
regulation of hormone biosynthetic process(GO:0046885) |
| 0.6 |
4.3 |
GO:0008306 |
associative learning(GO:0008306) |
| 0.6 |
7.3 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.6 |
8.5 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.6 |
1.2 |
GO:0001957 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.6 |
4.8 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.6 |
2.4 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 0.6 |
1.8 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.6 |
3.0 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.6 |
5.4 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.6 |
7.2 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.6 |
3.0 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.6 |
1.2 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.6 |
3.0 |
GO:0061088 |
regulation of sequestering of zinc ion(GO:0061088) |
| 0.6 |
3.6 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.6 |
5.9 |
GO:0021954 |
central nervous system neuron development(GO:0021954) |
| 0.6 |
1.2 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.6 |
5.3 |
GO:0046146 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.6 |
1.8 |
GO:0061053 |
somite development(GO:0061053) |
| 0.6 |
1.8 |
GO:1903033 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.6 |
4.1 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.6 |
5.3 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.6 |
4.1 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.6 |
7.0 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.6 |
1.7 |
GO:0070092 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.6 |
2.9 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.6 |
0.6 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.6 |
2.3 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.6 |
1.1 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.6 |
3.4 |
GO:0097354 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.6 |
1.7 |
GO:0032966 |
negative regulation of collagen biosynthetic process(GO:0032966) positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.6 |
8.8 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.5 |
1.6 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
| 0.5 |
1.6 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.5 |
3.8 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.5 |
8.2 |
GO:0010863 |
positive regulation of phospholipase C activity(GO:0010863) |
| 0.5 |
2.7 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.5 |
2.1 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.5 |
4.3 |
GO:0035878 |
nail development(GO:0035878) |
| 0.5 |
1.6 |
GO:0060509 |
Type I pneumocyte differentiation(GO:0060509) |
| 0.5 |
2.1 |
GO:1901162 |
primary amino compound biosynthetic process(GO:1901162) |
| 0.5 |
6.4 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.5 |
0.5 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.5 |
6.9 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.5 |
1.6 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.5 |
2.1 |
GO:2000617 |
positive regulation of histone H3-K9 acetylation(GO:2000617) |
| 0.5 |
4.1 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.5 |
1.5 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.5 |
7.6 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.5 |
1.5 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.5 |
1.5 |
GO:0046021 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
| 0.5 |
6.1 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.5 |
2.5 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.5 |
2.0 |
GO:0034505 |
tooth mineralization(GO:0034505) |
| 0.5 |
7.5 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.5 |
2.5 |
GO:0033078 |
extrathymic T cell differentiation(GO:0033078) |
| 0.5 |
11.9 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.5 |
6.4 |
GO:1903859 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.5 |
3.9 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.5 |
5.4 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.5 |
2.5 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.5 |
1.9 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.5 |
7.3 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.5 |
1.5 |
GO:0021563 |
glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.5 |
3.4 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.5 |
9.7 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.5 |
2.9 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.5 |
3.9 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.5 |
14.8 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.5 |
1.4 |
GO:0009304 |
tRNA transcription(GO:0009304) |
| 0.5 |
3.8 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.5 |
7.1 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.5 |
1.4 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
| 0.5 |
0.9 |
GO:2000977 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) primitive erythrocyte differentiation(GO:0060319) regulation of forebrain neuron differentiation(GO:2000977) |
| 0.5 |
0.9 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.5 |
2.8 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.5 |
1.4 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.5 |
1.4 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.5 |
3.2 |
GO:0043649 |
dicarboxylic acid catabolic process(GO:0043649) |
| 0.5 |
3.2 |
GO:1904467 |
regulation of tumor necrosis factor secretion(GO:1904467) positive regulation of tumor necrosis factor secretion(GO:1904469) tumor necrosis factor secretion(GO:1990774) |
| 0.5 |
1.8 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.5 |
6.9 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.5 |
1.4 |
GO:0010543 |
regulation of platelet activation(GO:0010543) |
| 0.5 |
0.9 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.5 |
4.1 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.5 |
3.6 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.5 |
4.5 |
GO:2000169 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.5 |
3.6 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.4 |
7.6 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.4 |
12.5 |
GO:0019226 |
transmission of nerve impulse(GO:0019226) |
| 0.4 |
5.8 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.4 |
0.4 |
GO:1903626 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.4 |
7.1 |
GO:0006743 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.4 |
8.3 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.4 |
1.3 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.4 |
8.7 |
GO:0000732 |
strand displacement(GO:0000732) |
| 0.4 |
3.5 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.4 |
0.9 |
GO:0002775 |
antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.4 |
2.6 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.4 |
3.4 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.4 |
1.7 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.4 |
2.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.4 |
2.1 |
GO:0046512 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.4 |
1.7 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 0.4 |
2.9 |
GO:0010717 |
regulation of epithelial to mesenchymal transition(GO:0010717) |
| 0.4 |
10.4 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.4 |
4.1 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.4 |
5.4 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.4 |
2.8 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.4 |
3.7 |
GO:0006853 |
carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
| 0.4 |
4.5 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.4 |
10.1 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.4 |
1.6 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.4 |
12.1 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.4 |
8.8 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.4 |
3.2 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.4 |
2.0 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.4 |
10.0 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.4 |
2.8 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.4 |
10.2 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.4 |
8.6 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.4 |
3.9 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.4 |
0.4 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.4 |
6.2 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.4 |
6.6 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.4 |
3.1 |
GO:1900047 |
negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.4 |
13.9 |
GO:0046949 |
fatty-acyl-CoA biosynthetic process(GO:0046949) |
| 0.4 |
0.8 |
GO:0007600 |
sensory perception(GO:0007600) |
| 0.4 |
2.3 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.4 |
1.1 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.4 |
0.8 |
GO:0035655 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.4 |
2.6 |
GO:0061734 |
parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.4 |
3.3 |
GO:0006636 |
unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.4 |
2.2 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.4 |
1.1 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.4 |
1.1 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.4 |
5.9 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.4 |
1.8 |
GO:0009948 |
anterior/posterior axis specification(GO:0009948) |
| 0.4 |
1.8 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 0.4 |
2.6 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.4 |
15.7 |
GO:0001523 |
retinoid metabolic process(GO:0001523) |
| 0.4 |
4.0 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.4 |
0.7 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.4 |
1.1 |
GO:0050732 |
negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
| 0.4 |
2.5 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) |
| 0.4 |
30.9 |
GO:0007586 |
digestion(GO:0007586) |
| 0.4 |
1.4 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.4 |
4.3 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.4 |
1.8 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.4 |
2.8 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.4 |
1.4 |
GO:0006837 |
serotonin transport(GO:0006837) |
| 0.4 |
4.2 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.4 |
5.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.3 |
3.1 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.3 |
1.0 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.3 |
0.3 |
GO:0032536 |
regulation of cell projection size(GO:0032536) |
| 0.3 |
2.4 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.3 |
3.1 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.3 |
5.8 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.3 |
0.7 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.3 |
2.4 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.3 |
14.0 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.3 |
2.0 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.3 |
5.8 |
GO:2000479 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.3 |
0.7 |
GO:0010455 |
positive regulation of cell fate commitment(GO:0010455) |
| 0.3 |
1.3 |
GO:0032527 |
protein exit from endoplasmic reticulum(GO:0032527) |
| 0.3 |
4.7 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.3 |
8.0 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.3 |
4.3 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.3 |
7.9 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 |
5.9 |
GO:0034113 |
heterotypic cell-cell adhesion(GO:0034113) |
| 0.3 |
3.6 |
GO:0060291 |
long-term synaptic potentiation(GO:0060291) |
| 0.3 |
2.6 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.3 |
1.6 |
GO:0060215 |
primitive hemopoiesis(GO:0060215) |
| 0.3 |
5.5 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.3 |
1.6 |
GO:0046855 |
inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
| 0.3 |
2.6 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.3 |
19.1 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.3 |
20.0 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.3 |
11.4 |
GO:0006633 |
fatty acid biosynthetic process(GO:0006633) |
| 0.3 |
1.3 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.3 |
5.0 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.3 |
2.2 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.3 |
0.9 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.3 |
4.3 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.3 |
2.5 |
GO:0006312 |
mitotic recombination(GO:0006312) |
| 0.3 |
8.3 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.3 |
1.8 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.3 |
6.1 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.3 |
1.8 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.3 |
0.3 |
GO:0003418 |
chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) growth plate cartilage chondrocyte differentiation(GO:0003418) chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.3 |
1.2 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.3 |
2.1 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) |
| 0.3 |
1.5 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.3 |
3.5 |
GO:0035272 |
exocrine system development(GO:0035272) |
| 0.3 |
0.6 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.3 |
1.7 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.3 |
7.6 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.3 |
1.1 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.3 |
9.4 |
GO:0007339 |
binding of sperm to zona pellucida(GO:0007339) |
| 0.3 |
1.4 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.3 |
3.1 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.3 |
1.1 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
| 0.3 |
5.6 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.3 |
0.3 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.3 |
1.4 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.3 |
2.7 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.3 |
2.7 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.3 |
0.5 |
GO:0060547 |
negative regulation of necroptotic process(GO:0060546) negative regulation of necrotic cell death(GO:0060547) |
| 0.3 |
0.3 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.3 |
17.0 |
GO:1903825 |
organic acid transmembrane transport(GO:1903825) |
| 0.3 |
3.7 |
GO:0003298 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.3 |
1.3 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.3 |
1.1 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.3 |
0.8 |
GO:0007606 |
sensory perception of chemical stimulus(GO:0007606) |
| 0.3 |
5.4 |
GO:0007416 |
synapse assembly(GO:0007416) |
| 0.3 |
2.6 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.3 |
2.8 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.3 |
3.1 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 |
0.8 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
2.2 |
GO:0090313 |
regulation of protein targeting to membrane(GO:0090313) positive regulation of protein targeting to membrane(GO:0090314) |
| 0.2 |
18.7 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.2 |
3.7 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.2 |
6.1 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.2 |
0.7 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.2 |
1.2 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 |
1.0 |
GO:0042551 |
neuron maturation(GO:0042551) |
| 0.2 |
1.9 |
GO:0050852 |
T cell receptor signaling pathway(GO:0050852) |
| 0.2 |
8.5 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.2 |
12.0 |
GO:0044243 |
multicellular organism catabolic process(GO:0044243) |
| 0.2 |
2.3 |
GO:0009887 |
organ morphogenesis(GO:0009887) |
| 0.2 |
2.1 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.2 |
0.7 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 0.2 |
3.3 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.2 |
0.2 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.2 |
0.5 |
GO:0060586 |
multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.2 |
0.9 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 |
6.9 |
GO:0000272 |
polysaccharide catabolic process(GO:0000272) |
| 0.2 |
6.2 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) |
| 0.2 |
0.9 |
GO:0050770 |
regulation of axonogenesis(GO:0050770) |
| 0.2 |
1.4 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.2 |
2.2 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.2 |
0.7 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 0.2 |
1.7 |
GO:0072540 |
T-helper 17 cell lineage commitment(GO:0072540) |
| 0.2 |
0.9 |
GO:0032689 |
negative regulation of interferon-gamma production(GO:0032689) |
| 0.2 |
1.5 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.2 |
1.0 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.2 |
3.8 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.2 |
1.0 |
GO:0010470 |
regulation of gastrulation(GO:0010470) |
| 0.2 |
3.2 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.2 |
1.2 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.2 |
1.6 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 |
0.6 |
GO:0032769 |
negative regulation of monooxygenase activity(GO:0032769) |
| 0.2 |
0.4 |
GO:0043605 |
cellular amide catabolic process(GO:0043605) |
| 0.2 |
0.2 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.2 |
0.2 |
GO:0019377 |
glycolipid catabolic process(GO:0019377) |
| 0.2 |
1.9 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.2 |
1.0 |
GO:1902775 |
mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.2 |
2.5 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.2 |
4.5 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.2 |
0.9 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.2 |
1.1 |
GO:1904350 |
regulation of protein catabolic process in the vacuole(GO:1904350) positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.2 |
2.6 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.2 |
2.0 |
GO:0006023 |
aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.2 |
1.1 |
GO:0071396 |
cellular response to lipid(GO:0071396) |
| 0.2 |
8.2 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.2 |
0.5 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.2 |
0.7 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.2 |
1.7 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.2 |
0.9 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
| 0.2 |
3.4 |
GO:0060021 |
palate development(GO:0060021) |
| 0.2 |
1.0 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.2 |
2.3 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.2 |
1.0 |
GO:0030421 |
defecation(GO:0030421) |
| 0.2 |
4.1 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.2 |
4.9 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.2 |
0.6 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 |
3.7 |
GO:0007224 |
smoothened signaling pathway(GO:0007224) |
| 0.2 |
0.5 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.2 |
0.3 |
GO:0032634 |
interleukin-5 production(GO:0032634) regulation of interleukin-5 production(GO:0032674) |
| 0.2 |
0.5 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 |
0.6 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.2 |
8.0 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.2 |
16.7 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.1 |
1.9 |
GO:0006473 |
protein acetylation(GO:0006473) |
| 0.1 |
0.3 |
GO:0002727 |
natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 0.1 |
0.4 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.1 |
1.3 |
GO:0006026 |
aminoglycan catabolic process(GO:0006026) |
| 0.1 |
5.9 |
GO:0006687 |
glycosphingolipid metabolic process(GO:0006687) |
| 0.1 |
0.6 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 |
1.2 |
GO:0034394 |
protein localization to cell surface(GO:0034394) |
| 0.1 |
1.6 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.1 |
4.7 |
GO:0042445 |
hormone metabolic process(GO:0042445) |
| 0.1 |
0.7 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 |
3.1 |
GO:0032608 |
interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
| 0.1 |
0.4 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.1 |
1.0 |
GO:0032418 |
lysosome localization(GO:0032418) |
| 0.1 |
1.0 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.8 |
GO:2000178 |
negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.1 |
3.1 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.1 |
1.5 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
0.8 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 |
0.8 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.1 |
0.3 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 |
0.9 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
1.4 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
| 0.1 |
1.4 |
GO:0002715 |
regulation of natural killer cell mediated immunity(GO:0002715) |
| 0.1 |
0.2 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.9 |
GO:0061045 |
negative regulation of wound healing(GO:0061045) |
| 0.1 |
1.8 |
GO:0035914 |
skeletal muscle cell differentiation(GO:0035914) |
| 0.1 |
0.4 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 |
0.4 |
GO:0003096 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 |
2.7 |
GO:0044264 |
cellular polysaccharide metabolic process(GO:0044264) |
| 0.1 |
1.8 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.1 |
1.4 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.1 |
0.3 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 |
0.6 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 |
0.2 |
GO:0090290 |
positive regulation of osteoclast proliferation(GO:0090290) |
| 0.1 |
0.4 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.1 |
1.3 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.1 |
0.4 |
GO:0002501 |
peptide antigen assembly with MHC protein complex(GO:0002501) |
| 0.1 |
1.7 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.1 |
0.8 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
0.5 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.1 |
0.5 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
1.1 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 |
0.1 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.7 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.1 |
1.9 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 |
1.4 |
GO:0051058 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 |
0.3 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 |
0.1 |
GO:0070071 |
proton-transporting two-sector ATPase complex assembly(GO:0070071) |
| 0.1 |
1.8 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.1 |
0.3 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.1 |
0.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
0.2 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.0 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.0 |
0.5 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.0 |
0.5 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.0 |
0.1 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 0.0 |
0.2 |
GO:0071398 |
cellular response to fatty acid(GO:0071398) |
| 0.0 |
0.7 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.0 |
0.4 |
GO:0032006 |
regulation of TOR signaling(GO:0032006) |
| 0.0 |
2.0 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.2 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 |
0.1 |
GO:0035176 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 |
0.2 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 |
0.1 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.0 |
0.6 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 |
0.7 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.0 |
0.1 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.1 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.0 |
0.4 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.2 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.0 |
0.3 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.0 |
5.5 |
GO:0048232 |
spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
| 0.0 |
0.3 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.1 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.0 |
0.1 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.0 |
0.1 |
GO:0003299 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.3 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.0 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.0 |
0.0 |
GO:0032095 |
regulation of response to food(GO:0032095) regulation of appetite(GO:0032098) |